⬆
X
By continuing to use the site, you allow the use of Cookies and agree to the privacy policy.
.,о.,р..и.:г,.и.,н.;н.,а;,л.. .,н.:а,.х.,о.,д.;и.,т..с.:я,, ..н.;а., .,k;,i..b.:e,;r.,i.,s.,.;.r.:u,

Comparison results

 
Results: Differences General ✘Colliquative tuberculosis of the skin✘Tuberculosis of the eyes
Related research Analogs Analogs
Register, to see more distinctive signs of diseases and studies 43%(1)26%(6)
Histological studies 37%(0)27%(0)
Measurements at the reception 24%(0)—
Blood biochemistry —18%(1)
Distinctive symptoms
Register, to see more distinctive signs of diseases and studies 100%—
Register, to see more distinctive signs of diseases and studies —90%
the Mantoux reaction 70% —
suffocating — 76%
silicotuberculosis 69% —
tuberculosis of the eyes — 57%
cold allergy 59% —
bullous emphysema of the lung — 57%
hyperemia of skin folds 56% —
lung cyst — 54%
lymph node damage 55% —
cysts — 51%
soreness of axillary lymph nodes 55% —
blisters — 51%
hydradenitis 55% —
bronchial asthma — 48%
vulgar ektima 52% —
impressionability — 43%
colliquative tuberculosis of the skin 51% —
inflammation of the eyes — 34%
enlarged submandibular lymph nodes 49% —
visual impairment — 34%
tuberculosis in children 48% —
eye surgery — 34%
actinomycosis 47% —
tuberculosis 68% 100%
nodular erythema 45% —
nose large eyes — 32%
rash in the armpit area 45% —
pulmonary tuberculosis — 31%
pain in the armpit 44% —
corneal precipitates — 30%
dermatitis 43% —
blurred vision — 29%
no knots 43% —
shroud — 27%
tuberculosis in the anamnesis 42% —
uveit — 27%
rashes in the folds of the skin 41% —
basophilia — 26%
tuberculosis of the joints 40% —
nonspecific allergy — 25%
skin problems 55% 13%
tendency to allergies — 25%
purulent lymphadenitis 39% —
allergy eyes — 24%
suppuration with fistulas 38% —
disseminated tuberculosis — 24%
pyoderma 38% —
pain in the eyes — 23%
often sick child 38% —
s eyes cloudy — 23%
pain in the lymph nodes 37% —
focal pulmonary tuberculosis — 23%
closed person 37% —
retinal laser coagulation — 23%
purulent rashes on the skin 36% —
up vascular mesh — 23%
consequences of infection 36% —
progressive myopia — 22%
rash pustules 34% —
monocytosis — 22%
enlarged lymph nodes 34% —
flies in front of the eyes — 22%
inflammatory infiltrate 34% —
weak hazy vision — 21%
lymphadenitis 33% —
gray eyes — 21%
effects of puberty 32% —
tumors of the choroid — 21%
syphilis 32% —
retinitis — 20%
fistula 32% —
eosinophilia — 20%
red rash 32% —
heaviness in the eyes — 20%
reddening of the skin 31% —
allergic swelling — 19%
frequent colds 31% —
lacrimation — 19%
suppuration of the skin 30% —
crying during complaints — 19%
papules 58% 26%
conjunctivitis — 19%
immunodeficiency 29% —
slow onset of the disease — 19%
scarring 29% —
myopia — 19%
soreness of the skin 28% —
dark eyes — 19%
presses 28% —
acute allergic reactions — 19%
childhood diseases 25% —
there are no complaints — 19%
blood diseases 25% —
photophobia — 18%
patient's condition 24% —
glaucoma — 18%
history of surgery 40% 27%
increased calcium — 18%
drug disease 25% 13%
oncology — 18%
increased 33% 24%
increased intracranial pressure — 18%
drug allergy 29% 21%
allergy to medications — 17%
allergy 38% 31%
metastases — 16%
skin anesthesia — 15%
vascular tumor — 15%
impaired venous function — 14%
acute condition — 14%
anesthesia — 14%
subacute condition — 14%
intoxication — 14%
necrosis — 14%
impaired lung function — 14%
cancer — 14%
swelling — 13%
onset of illness — 13%
damage to the nervous system — 13%
inflammation 34% 46%
lowered — 12%

Instructions

Video
  1. Introduce new diseases through 🔍 Search and input on the top panel using
  2. The table shows the most important distinguishing symptoms, tests and diagnoses related to the selected diseases.
  3. The higher the percentage, the more important this symptom is for the disease and vice versa. At 0%, we can say that this symptom never occurs in the disease.
  4. The list changes dynamically depending on the data of the current visit in the selection of therapy .
  5. Click on the percentageto see the suggestions from the original source.
  6. By using the service, you agree to user agreement.